Kisspeptin-54 Triggers Gonadotropin Release at the Hypothalamic Level
Dhillo WS, Chaudhri OB, Patterson M, Thompson EL, Murphy KG, Badman MK, McGowan BM, Amber V, Patel S, Ghatei MA, Bloom SR
Journal of Clinical Endocrinology & Metabolism · Vol. 90(12) · pp. 6609–6615 · 2005
First human study demonstrating that kisspeptin-54 potently stimulates LH and FSH release in healthy men, establishing kisspeptin as a master regulator of the HPG axis. Foundational paper for kisspeptin's role in fertility, puberty, and reproductive endocrinology.
Citation
Key Findings
Kisspeptin-54 IV infusion produced 24-fold increase in LH and 4-fold increase in FSH
Dose-dependent gonadotropin release confirmed kisspeptin as a potent GnRH secretagogue
Effect mediated via hypothalamic GnRH neurons expressing KISS1R receptors
Establishes kisspeptin as the primary upstream regulator of the HPG reproductive axis
Opens therapeutic potential for infertility, hypogonadism, and pubertal disorders
Methodology
Randomized crossover study in healthy men. IV kisspeptin-54 infusion with serial LH, FSH, testosterone, and GnRH measurements.
Limitations
Acute single-dose study; chronic effects and therapeutic protocols require further development. Female reproductive axis response characterized in subsequent studies.
Protocols Using This Research
Tags
Educational use only. Research summaries are provided for informational purposes. Always consult the original publication and a qualified healthcare provider before making clinical decisions.
Related Research
Build a protocol around this research
Our AI Advisor incorporates the latest research to build a personalized peptide protocol for your goals.
Start Assessment